Rheumatology International

Papers
(The H4-Index of Rheumatology International is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review372
Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management220
SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis120
ANCA-associated vasculitis after COVID-1998
Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey94
The Beighton Score as a measure of generalised joint hypermobility85
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly76
Comorbidities in psoriatic arthritis: a systematic review and meta-analysis76
YouTube as a source of information on gout: a quality analysis74
Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews73
COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey70
Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review66
Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry62
Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey60
Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands57
Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis56
Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic56
COVID-19 pandemic in Japan52
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review50
Reactive arthritis after COVID-19: a case-based review49
Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent47
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis44
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol43
Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study42
Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic39
Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural–urban gap and north–south gradient39
Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development36
Sex hormones, autoimmunity and gender disparity in COVID-1935
Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting32
Prevalence of osteoarthritis in lower middle- and low-income countries: a systematic review and meta-analysis30
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study30
0.043233156204224